Early Access — free while we kick the tires
EdgarHawk

Sherman Darren

See Remarks

Director Officer
1 filing analyzed · 1 company · Latest 2025-08-25

Companies

Company Buys Sells Direction
Orchestra BioMed Holdings, Inc. OBIO 1 0 Net buying

Activity

August 2025
medium
Buy
3,000 shares
$7,860
Significance 5/10

Sherman Darren bought 3,000 shares of OBIO at $2.62; stock now $2.60, down 61.2% from 52-week high. Cluster pattern: 3 other insiders also bought in past 14 days.

Sherman Darren purchased 3,000 shares at $2.62 on 2025-08-25, increasing his holdings to 926,837 shares post-transaction. The stock has deteriorated significantly, trading at $2.60 (current price) versus a 52-week high of $6.70, representing a decline of 61.2% from peak. The company fundamentals are challenged: net income was $-19,363,000.00 over the most recent full fiscal year, and quarterly revenue stands at $836,000.00 with annual revenue growth of -4.4%. Notably, this purchase is part of a cluster pattern—3 other insiders also bought within the past 14 days—suggesting coordinated or synchronized accumulation at depressed levels. The convergence of multiple insider purchases amid material stock weakness and sustained unprofitability warrants attention to whether this reflects insider assessment of value or other factors driving the coordinated activity.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access